Home › Onyx confirms, rejects Amgen's $120-per-share bid
 

Keywords :   


Onyx confirms, rejects Amgen's $120-per-share bid

2013-06-30 21:11:06| Biotech - Topix.net

Onyx Pharmaceuticals Inc. on Sunday confirmed that it received an unsolicited takeover bid from Amgen Inc. for $120 per share.

Tags: bid confirms rejects onyx

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10'Rightmove is my porn' - the addiction to online property search
06.10Eastern North Pacific Tropical Weather Outlook
06.10Atlantic Tropical Weather Outlook
05.10Tropical Storm Milton Public Advisory Number 2
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 26
05.10Tropical Storm Milton Graphics
05.10Hurricane Kirk Wind Speed Probabilities Number 26
More »